JP2024523576A5 - - Google Patents
Info
- Publication number
- JP2024523576A5 JP2024523576A5 JP2023579654A JP2023579654A JP2024523576A5 JP 2024523576 A5 JP2024523576 A5 JP 2024523576A5 JP 2023579654 A JP2023579654 A JP 2023579654A JP 2023579654 A JP2023579654 A JP 2023579654A JP 2024523576 A5 JP2024523576 A5 JP 2024523576A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2109946.0 | 2021-07-09 | ||
| GBGB2109946.0A GB202109946D0 (en) | 2021-07-09 | 2021-07-09 | New compounds |
| GBGB2202664.5A GB202202664D0 (en) | 2022-02-25 | 2022-02-25 | New compounds |
| GB2202664.5 | 2022-02-25 | ||
| PCT/GB2022/051760 WO2023281271A1 (en) | 2021-07-09 | 2022-07-08 | New selective angiotensin ii compounds |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024523576A JP2024523576A (ja) | 2024-06-28 |
| JPWO2023281271A5 JPWO2023281271A5 (https=) | 2025-07-15 |
| JP2024523576A5 true JP2024523576A5 (https=) | 2025-07-15 |
Family
ID=82608432
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023579654A Pending JP2024523576A (ja) | 2021-07-09 | 2022-07-08 | 新規の選択的アンジオテンシンｉｉ化合物 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20240262813A1 (https=) |
| EP (1) | EP4367110A1 (https=) |
| JP (1) | JP2024523576A (https=) |
| KR (1) | KR20240035402A (https=) |
| AU (1) | AU2022306778A1 (https=) |
| CA (1) | CA3222721A1 (https=) |
| CL (1) | CL2024000066A1 (https=) |
| CO (1) | CO2024000096A2 (https=) |
| IL (1) | IL309605A (https=) |
| MX (1) | MX2024000518A (https=) |
| WO (1) | WO2023281271A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2024000518A (es) | 2021-07-09 | 2024-01-31 | Vicore Pharma Ab | Nuevos compuestos selectivos de angiotensina ii. |
| WO2024149712A1 (en) * | 2023-01-09 | 2024-07-18 | Vicore Pharma Ab | Selective angiotensin ii compounds |
| CN119504723A (zh) * | 2023-08-25 | 2025-02-25 | 武汉人福创新药物研发中心有限公司 | 作为at2r激动剂的噻吩磺酰基氨基甲酸酯 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5464853A (en) | 1993-05-20 | 1995-11-07 | Immunopharmaceutics, Inc. | N-(5-isoxazolyl)biphenylsulfonamides, N-(3-isoxazolyl)biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin |
| US5198438A (en) | 1991-05-07 | 1993-03-30 | Merck & Co., Inc. | Angiotensin ii antagonists incorporating a substituted thiophene or furan |
| US5312820A (en) | 1992-07-17 | 1994-05-17 | Merck & Co., Inc. | Substituted carbamoyl and oxycarbonyl derivatives of biphenylmethylamines |
| US5444067A (en) | 1993-08-30 | 1995-08-22 | Merck & Co., Inc. | Pharmaceutical treatment methods using angiotensin II receptor agonists bearing a thiophene moiety |
| HUP9802034A3 (en) | 1995-04-04 | 2000-04-28 | Encysive Pharmaceuticals Inc H | Thienyl-, furyl-, pyrrolyl- and biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin and use of the compounds |
| US5846990A (en) * | 1995-07-24 | 1998-12-08 | Bristol-Myers Squibb Co. | Substituted biphenyl isoxazole sulfonamides |
| SE9800550D0 (sv) | 1998-02-24 | 1998-02-24 | A & Science Invest Ab | A pharmaceutical preparation comprising an angiotensin II type 2 receptor agonist, and use thereof |
| WO2000001389A1 (en) * | 1998-07-06 | 2000-01-13 | Bristol-Myers Squibb Co. | Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| CA2449150C (en) | 2001-05-31 | 2011-07-12 | Vicore Pharma Ab | Tricyclic compounds useful as angiotensin ii agonists |
| KR100938817B1 (ko) * | 2001-05-31 | 2010-01-26 | 바이코어 파마 아베 | 안지오텐신 ⅱ 작용제로 유용한 삼중고리 화합물 |
| WO2004046141A1 (en) | 2002-11-21 | 2004-06-03 | Vicore Pharma Ab | New tricyclic angiotensin ii agonists |
| MX2008011227A (es) * | 2006-03-03 | 2009-02-10 | Torrent Pharmaceuticals Ltd | Receptores antagonistas de accion nueva y doble en los receptores at1 y eta. |
| US8835471B2 (en) * | 2010-06-11 | 2014-09-16 | Vicore Pharma Ab | Use of angiotensin II agonists |
| BR112017012337A2 (pt) | 2014-12-12 | 2018-02-27 | Vicore Pharma Ab | Método para tratamento de doença falciforme, agonista do receptor at2, ou um sal farmaceuticamente aceitável, solvato ou pró- fármaco do mesmo, uso de um agonista do receptor at2, ou um sal farmaceuticamente aceitável, solvato ou pró-fármaco do mesmo, formulação farmacêutica, e, produto de combinação. |
| WO2016107879A2 (en) | 2014-12-30 | 2016-07-07 | Vicore Pharma Ab | New use of angiotensin ii receptor agonists |
| CN107405406A (zh) | 2015-03-02 | 2017-11-28 | 维科尔药物公司 | 用于治疗肺纤维化的血管紧张素ii受体激动剂 |
| WO2017221012A1 (en) | 2016-06-21 | 2017-12-28 | Vicore Pharma Ab | Methods and compositions for preventing or reducing the risk of cancer treatment-related cardiotoxicity |
| GB201710906D0 (en) | 2017-07-06 | 2017-08-23 | Vicore Pharma Ab | Compounds and methods for treating peripheral neuropathy |
| GB201913603D0 (en) * | 2019-09-20 | 2019-11-06 | Vicore Pharma Ab | New compounds |
| KR20230004501A (ko) * | 2020-03-19 | 2023-01-06 | 바이코어 파마 아베 | 안지오텐신 ⅱ와 관련된 질병, 장애, 또는 병태의 치료 및/또는 예방에 유용한 신규 화합물 |
| MX2024000518A (es) | 2021-07-09 | 2024-01-31 | Vicore Pharma Ab | Nuevos compuestos selectivos de angiotensina ii. |
-
2022
- 2022-07-08 MX MX2024000518A patent/MX2024000518A/es unknown
- 2022-07-08 CA CA3222721A patent/CA3222721A1/en active Pending
- 2022-07-08 JP JP2023579654A patent/JP2024523576A/ja active Pending
- 2022-07-08 IL IL309605A patent/IL309605A/en unknown
- 2022-07-08 US US18/577,856 patent/US20240262813A1/en active Pending
- 2022-07-08 KR KR1020237044464A patent/KR20240035402A/ko active Pending
- 2022-07-08 EP EP22743876.9A patent/EP4367110A1/en active Pending
- 2022-07-08 AU AU2022306778A patent/AU2022306778A1/en active Pending
- 2022-07-08 WO PCT/GB2022/051760 patent/WO2023281271A1/en not_active Ceased
-
2024
- 2024-01-08 CL CL2024000066A patent/CL2024000066A1/es unknown
- 2024-01-09 CO CONC2024/0000096A patent/CO2024000096A2/es unknown
- 2024-12-10 US US18/975,881 patent/US12441718B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024523576A5 (https=) | ||
| CL2025004093A1 (es) | Anticuerpos de unión a proteína de activación de fibroblastos alfa y receptor de muerte 4 | |
| CA3246145A1 (https=) | ||
| BR102023014872A2 (https=) | ||
| BR102023012440A2 (https=) | ||
| BR102023010976A2 (https=) | ||
| BR102023009641A2 (https=) | ||
| BR202022009269U2 (https=) | ||
| BR202022000931U2 (https=) | ||
| CN307047720S (https=) | ||
| CN307045722S (https=) | ||
| BY13151U (https=) | ||
| BY13150U (https=) | ||
| BY13149U (https=) | ||
| BY13145U (https=) | ||
| BY13144U (https=) | ||
| BY13143U (https=) | ||
| CN307050031S (https=) | ||
| CN307050025S (https=) | ||
| CN307049776S (https=) | ||
| CN307048405S (https=) | ||
| CN307048118S (https=) | ||
| BY13142U (https=) | ||
| BY13141U (https=) | ||
| BY13155U (https=) |